Kenta Fujiyama
Papers
1
Total Citations
4
H-Index
1
About
Kenta Fujiyama is a urological surgeon and researcher whose work centers on improving outcomes for prostate cancer patients, particularly through the refinement of surgical techniques and postoperative risk stratification. His major contribution lies in developing a novel risk classification system that leverages the detailed status of positive surgical margins (PSM) to more accurately predict biochemical recurrence (BCR) following robot-assisted radical prostatectomy (RARP). In a landmark 2024 study analyzing 427 patients, Fujiyama demonstrated that the precise location, extent, and number of positive margins offer superior prognostic value compared to traditional binary margin assessment. This work, already garnering early citations, provides clinicians with a practical tool to tailor adjuvant therapy and surveillance strategies, potentially sparing low-risk patients from overtreatment while intensifying follow-up for those at higher risk. By moving beyond a simple "positive or negative" margin designation, Fujiyama has advanced the precision of surgical oncology. His research bridges the gap between operative pathology and personalized medicine, offering a tangible framework to reduce recurrence rates and improve long-term quality of life for men undergoing robotic prostate surgery.
Research Focus
Key Achievements
Top Papers
- 1